BAPRAS acknowledges FDA safety communication on soft tissue fillers

10th June 2015

 

BAPRAS has recently become aware of a recent FDA safety communication on soft tissue fillers which was communicated to all American physicians

Soft tissue fillers are FDA-approved to reduce the appearance of wrinkles or to augment lips or cheeks.

Soft tissue fillers should be injected only by health care providers who have appropriate training and experience and who are knowledgeable about the anatomy at and around the injection site.

For the full communication from the FDA visit their website here

 

Back to list page
News and Views